From October 1, 2023 to December 21, 2023, the company has repurchased 2,251,804 shares, representing 0.54% for CNY 74.8 million. With this, the company has completed the repurchase of 2,982,382 shares, representing 0.72% for CNY 99.99 million under the buyback announced on September 18, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.29 CNY | +0.59% | -0.58% | -16.06% |
20/05 | Wall Street Cues, Central Bank Outlooks Lift Asian Stock Markets | MT |
29/04 | Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.06% | 1.56B | |
-1.85% | 89.87B | |
-3.95% | 37.57B | |
+61.85% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+3.90% | 9.11B | |
-19.53% | 7.32B |
- Stock Market
- Equities
- 688739 Stock
- News Liaoning Chengda Biotechnology Co.,Ltd.
- Tranche Update on Liaoning Chengda Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on September 18, 2023.